Cargando…
PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib
Sorafenib is currently the only systemic agent approved for treatment of advanced hepatocellular carcinoma (HCC). However, intrinsic and acquired resistance to sorafenib remains a great challenge with respect to improving the prognoses of patients with HCC. The cyto-protective functions of autophagy...
Autores principales: | Zhang, Kai, Chen, Jing, Zhou, Hao, Chen, Ying, Zhi, Yingru, Zhang, Bei, Chen, Longbang, Chu, Xiaoyuan, Wang, Rui, Zhang, Chunni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833744/ https://www.ncbi.nlm.nih.gov/pubmed/29472524 http://dx.doi.org/10.1038/s41419-018-0344-0 |
Ejemplares similares
-
Nondegradative Role of Atg5-Atg12/ Atg16L1 Autophagy Protein Complex in Antiviral Activity of Interferon Gamma
por: Hwang, Seungmin, et al.
Publicado: (2012) -
The phenotypes of ATG9, ATG16 and ATG9/16 knock-out mutants imply autophagy-dependent and -independent functions
por: Xiong, Qiuhong, et al.
Publicado: (2015) -
MicroRNA-106a Inhibits Autophagy Process and Antimicrobial Responses by Targeting ULK1, ATG7, and ATG16L1 During Mycobacterial Infection
por: Liu, Kunmei, et al.
Publicado: (2021) -
TMEM74 promotes tumor cell survival by inducing autophagy via interactions with ATG16L1 and ATG9A
por: Sun, Yizhe, et al.
Publicado: (2017) -
Uba1 functions in Atg7- and Atg3-independent autophagy
por: Chang, Tsun-Kai, et al.
Publicado: (2013)